Study of AMG 509 in Participants With Metastatic Castration-Resistant Prostate Cancer

NCT04221542 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

479

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: AMG 509
DRUG: Abiraterone
DRUG: Enzalutamide

Sponsor

Amgen

Collaborators

[object Object]
[object Object]